Senior insider sale
REGENERON PHARMACEUTICALS, INC. — senior position signals high conviction
$320.4K
500.00 shares
What this filing means
RYAN ARTHUR F plans to sell 500.00 shares of REGENERON PHARMACEUTICALS, INC. valued at approximately $320.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001968582-26-000693
Director
Since Mar 2026
500.00
Shares to sell
$320.4K
Approx. market value
400.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Compensation
N/A
8/22/2013
400.00Total acquired400.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/22/2013 | Compensation N/A | 400.00 | — |
| Total | 400.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
100.00
Market value
$70.5K
5/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
400.00
Market value
$249.9K
7/2/2026
Total
Units
500.00
Value
$320.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2026 | 100.00 | $70.5K | — | Completed |
| Planned — Approximate Date | ||||
7/2/2026 | 400.00 | $249.9K | NASDAQ | Planned |
| Total | 500.00 | $320.4K | ||